Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.
Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.
Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.
-Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
more-Naming Biopharmaceutical Products 1 Monoclonal Antibody Drugs
more-Naming Biopharmaceutical Products 1 Monoclonal Antibody Drugs
moreCopyright Samsung Biologics. All rights reserved